OVID – ovid therapeutics inc. (US:NASDAQ)
Stock Stats
News
Ovid Therapeutics Inc. (NASDAQ: OVID) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting [Yahoo! Finance]
Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual Meeting
Ovid Therapeutics (OVID) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results
Form 4 Ovid Therapeutics Inc. For: Dec 12 Filed by: Friedman Bart
Form 4 Ovid Therapeutics Inc. For: Dec 12 Filed by: Duncan Barbara Gayle
Form 4 Ovid Therapeutics Inc. For: Dec 12 Filed by: Bernstein Karen
Form 4 Ovid Therapeutics Inc. For: Dec 12 Filed by: Fitzgerald Kevin Joseph
Form SC 13G/A Ovid Therapeutics Inc. Filed by: EcoR1 Capital, LLC
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.